During this time of heightened concern regarding COVID-19, we want to provide you with timely updates on our plans to do our part and share the steps we’re taking to ensure healthcare providers and patients continue to receive uninterrupted support from AMAG Pharmaceuticals.
We are focused on keeping employees and our communities safe and have instituted a work from home policy through April 3, in order to help slow the spread of COVID-19. An AMAG Task Force has been formed to monitor this evolving situation and determine if this time period needs to be extended.
As such, sales representatives and medical science liaisons (MSLs) will not be visiting provider offices or institutions, which we believe is important to help protect patient health and facilitate providers’ attention to direct patient care during this challenging situation.
AMAG currently markets Makena®, Feraheme®, Vyleesi® and Intrarosa®. All remain available to patients. Our supply chain has not been affected by this situation and AMAG continues to closely monitor supply levels and will work diligently to mitigate disruption to patients, should any arise. Our patient support hubs for Makena and Feraheme remain available, as well as our copay programs for Vyleesi and Intrarosa. If providers or patients have questions, please call a Care Manager at the respective patient support program or specialty pharmacy noted below.
- Makena Care Connection: 1-800-847-3418 available from 8 AM ET to 8 PM ET, Monday through Friday
- Feraheme Assist: 1-844-635-2624 available from 8 AM ET to 8 PM ET, Monday through Friday
- Avella Specialty Pharmacy for Vyleesi: 877-546-5779 available 24 hours a day, 7 days a week
- BioPlus Specialty Pharmacy for Vyleesi: 866-541-8082 available 24 hours a day, 7 days a week
Providers can reach their sales representatives and MSLs via phone with requests. These employees will also be reaching out to provider offices via email to inquire if there are any needs they can fulfill remotely. If you do not have contact information to reach your AMAG representative, please contact AMAG medical information at 1-877-411-2510 or amag@druginfo.com so that we may respond to your request.
We know healthcare providers and their staff are on the front-line providing care for many high-risk patients at an unprecedented time with considerable uncertainty. We appreciate their efforts and wish them and their patients well. Thank you for understanding our decision.
